Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer

Christine Feig, James O. Jones, Matthew Kraman, Richard J. B. Wells, Andrew Deonarine, Derek S. Chan, Claire M. Connell, Edward W. Roberts, Qi Zhao, Otávia L. Caballero, Sarah Amalia Teichmann, Tobias Janowitz, Duncan Ian Jodrell, David Arthur Tuveson, Douglas T. Fearon

View at source ↗Article2,098 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1073/pnas.1320318110
Published
Nov 25, 2013
Venue
Proceedings of the National Academy of Sciences
DOI
10.1073/pnas.1320318110
PubMed
24277834
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics